Abstract Coronaviruses (CoVs), enveloped positive-sense RNA viruses, are a group of
viruses that cause infections in the human respiratory tract, which can be characterized …

During recent years, we are moving away from the 'one exposure, one disease'-approach in
occupational settings and towards a more comprehensive approach, taking into account the …

Abstract Beta-2 adrenergic receptors (β2-ARs) have important roles in the pathogenesis and
treatment of chronic obstructive pulmonary disease (COPD). In recent years, progress has …

Background and Objectives: Tachycardia is a common cardiovascular disease. Drugs
blocking β1-adrenergic receptors (ADRB1) are used in the therapy of arrhythmogenic heart …

The field of pharmacogenetics, the investigation of the influence of one or more sequence
variants on drug response phenotypes, is a special case of pharmacogenomics, a discipline …

Adipose tissue is a central regulator of metabolism and an important pharmacological target
to treat the metabolic consequences of obesity, such as insulin resistance and dyslipidemia …

Abdominal aortic aneurysm (AAA) is a life‐threatening vascular disease but effective drugs
for treatment of AAA are still lacking. Recently, erythropoietin (EPO) is reported to induce …

Cardiovascular diseases are a well‐established cause of death in high‐income countries. In
the last 20 years, Sub‐Saharan Africa (SSA) has seen one of the sharpest increases in …

β-blockers have been widely utilized as a part of acute myocardial infarction (AMI) treatment
for the past 40 years. Patients receiving β-adrenergic blockers for an extended period …

Trauma is a serious public health issue, and remains a major cause of mortality and
disability worldwide. The notion that genetic factors contribute to an individual's response to …